What is Deepsight Technology?
Founded in 2019 and based in San Francisco, DeepSight Technology is at the forefront of developing advanced computer vision sensing technologies. The company specializes in diagnostic medical imaging, aiming to enhance the accuracy and efficiency of medical diagnoses through innovative AI-driven solutions. Their focus on this critical intersection of technology and healthcare positions them as a key player in the rapidly evolving medtech landscape.
How much funding has Deepsight Technology raised?
Deepsight Technology has raised a total of $25M across 1 funding round:
Series A
$25M
Series A (2021): $25M with participation from Wing Venture Capital, Alter Venture Partners, Deerfield, and Time BioVentures
Key Investors in Deepsight Technology
Wing Venture Capital
Wing Venture Capital is an early-stage investor focused on equipping founders with resources and unwavering partnerships to develop innovative products, particularly in areas such as AI and data.
Alter Venture Partners
Alter Venture Partners is a Venture Capital Fund that focuses on disruptive Enterprise companies, supporting startups in their innovation and scaling efforts, including international expansion.
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment and intelligence, supporting companies across the healthcare ecosystem with flexible funding models.
What's next for Deepsight Technology?
The recent major strategic investment signals a pivotal growth phase for DeepSight Technology. This capital infusion is expected to accelerate product development, expand market reach, and further solidify its position in the competitive diagnostic imaging market. The company's trajectory suggests a focus on scaling operations and potentially exploring new applications for its core computer vision technology within the broader healthcare ecosystem.
See full Deepsight Technology company page
